1.RADIOTHERAPY OF MALIGNANT PLEURAL EFFUSION WITH MOVING STRIP TECHNIQUE
Jishun HU ; Zhongji MA ; Zeda JIANG
Chinese Journal of Radiation Oncology 1992;0(01):-
From Oct. 1985 through 1989, 38 patients with malignant pleural effusion were treated with 60Co moving strip technic. Complete response was 19/38 and marked response 10/38. The 1-,2-, and 3-year survival rates were 42.9%, 33.2% and 4.8% in radiation only group. The 1-, 2-, and 3 year survial rates were 47.1%, 35.3%, 11.8% in radiation combined with chemotherapy group. It is proved that radiation be surperior to intracavitary chemotherapy or radiation combind with systemic chemotherapy. This treatmet is safe and well tolerated by patients.
2.CLINICAL ANALYSIS OF TEN PATIENTS WITH RADIATION PNEUMONITIS
Jishun HU ; Zhongji MA ; Zeda JIANG
Chinese Journal of Radiation Oncology 1992;0(04):-
From Jan. 1987 to Dec. 1988, a total of 230 patients (135 lung cancer, 95 breast cancer) were treated by irradiation. The frequency of radiation pneumonitis was 5.1%(7/135) in lung cancer and 3.1%(3/95) in breast cancer. The frequency of lung cancer (n=16) complicated with pleunal effusion and treated by whole chest moving-strip irradiation was 31.2%(5/16) as compared with 2.3%(5/214) in those treated by the conventional radiation. The incidence of radiation pneumonitis was related to dose in the target volume, area of radiation and chemotherapy before radiotherapy.
3.Association of microalbuminuria and von Willebrand factor with metabolic syndrome in hypertensive patients
Jing LIU ; Jing YANG ; Ningling SUN ; Jishun MA ; Dayi HU
Journal of Peking University(Health Sciences) 2003;0(06):-
Objective:To compare the difference of microalbuminuria (MAU) and von Willebrand factor (vWF) between essential hypertensives and hypertensive patients with metabolic syndrome (MS), and to explore the association of these factors with MS. Methods: According to the new definition of MS by International Diabetes Federation (IDF) for 2005, 133 consecutive essential hypertensives were divi-ded into two groups: hypertensive patients with metabolic syndrome (EH-MS group, n=97), and essential hypertensives (EH group, n=36). Biochemistry assay, plasma vWF, 24 hours urine albumin excretion (UAE) and morning urine albumin/creatinine ratio (ACR) were measured. The association of MAU and vWF with MS was analysed. Results: Waist circumference, body mass index, triglyceride (TG), low density lipoprotein cholesterol (LDL-C), plasma vWF and UAE were increased(P0.05, respectively). Logistic regression showed HDL-C, TG, LDL-C,vWF and UAE were associated with the deve-lopment of MS in hypertensive patients (standardized coefficients: -0.825, 0.63, 0.339, 0.331, 0.371,P
4.Inflammatory Factors and von Willebrand Factor in Hypertensive Patients Complicated with Metabolic Syndrome
Jing LIU ; Zhongmin TANG ; Qian FAN ; Jishun MA ; Ningling SUN
Chinese Journal of Hypertension 2006;0(10):-
Objective To test the hypothese that metabolic syndrome is closely associated with inflammation, we compare the difference of inflammatory factors and von Willebrand factor between essential hypertensives and hypertensive patients with metabolic syndrome. Methods According to the new definition of metabolic syndrome by IDF 2005, one hundred thirty eight consecutive hospitalized essential hypertensives were catelogorized into EH+MS group, n=99 and EH alone group, n=39. Biochemistry assay, white blood cell (WBC) counts, serum high sensitive C reactive protein (hsCRP) and plasma von Willebrand factor (vWF) were measured. The relationship between hsCRP, vWF and MS were analysed. Results Waist circumference, body mass index, triglyceride, low density lipoprotein cholesterol (LDL-C), WBC, serum hsCRP and plasma vWF were increased(P